Company News in the Life Science Industry

»

Reset 

Interview with Gabriella's Kitchen CEO Margot Micallef -- CFN Media

Read more ››
By: Nasdaq / GlobenewsWire - 20 Mar 2019

Alexion and Zealand Pharma Announce Collaboration to Discover and Develop Peptide Therapies for Complement-Mediated Diseases

Read more ››
By: Nasdaq / GlobenewsWire - 20 Mar 2019
Related companies:  Zealand Pharma A/S

European Medicines Agengy Issues Certificates for Trogarzo® Manufacturing Sites

Read more ››
By: Nasdaq / GlobenewsWire - 20 Mar 2019
Related companies:  Theratechnologies Inc.

Zealand Pharma increases its share capital as a consequence of a new issue of shares

Read more ››
By: Nasdaq / GlobenewsWire - 20 Mar 2019
Related companies:  Zealand Pharma A/S

Mesa Biotech Named 2019 Frost & Sullivan Price/Performance Value Leader in Global Influenza Point-of-Care Testing

SAN DIEGO, March 20, 2019 /PRNewswire/ -- Mesa Biotech Inc., is a privately held, molecular diagnostic company that developed an affordable and easy to operate polymerase chain reaction (PCR) testing platform designed specifically for point-of-care (POC) infectious disease diagnosis. Today, Mesa... Read more ››

By: PR Newswire Association LLC. - 20 Mar 2019
Related companies:  FROST & SULLIVAN, BANGALORE | Frost & Sullivan | Frost & Sullivan, Australia

Merck Opens First M Lab(TM) Collaboration Center in Europe

- Molsheim, France center supports pharmaceutical and biotechnology customers from pre-clinical through full-scale production in non-GMP environment

Read more ››
By: PR Newswire Association LLC. - 20 Mar 2019
Related companies:  Merck KGaA | Merck Chemicals GmbH | Merck Serono GmbH

Merck and Pfizer Announce Discontinuation of Phase III JAVELIN Ovarian PARP 100 Trial in Previously Untreated Advanced Ovarian Cancer

DARMSTADT, Germany and NEW YORK, March 20, 2019 /PRNewswire/ -- Merck and Pfizer Inc. (NYSE: PFE) today announced the discontinuation of the ongoing Phase III JAVELIN Ovarian PARP 100 study evaluating the efficacy and safety of avelumab in combination with chemotherapy followed by maintenance... Read more ››

By: PR Newswire Association LLC. - 20 Mar 2019
Related companies:  Merck KGaA | Merck Chemicals GmbH | Merck Serono GmbH

AlzeCure Initiates New Drug Project Within Pain

STOCKHOLM, March 20, 2019 /PRNewswire/ -- AlzeCure Pharma AB (publ) (FN STO: ALZCUR) today announced that it has started a new preclinical drug project, TrkA-NAM, which is based on the company's research platform NeuroRestore.

Read more ››
By: PR Newswire Association LLC. - 20 Mar 2019
Related companies:  AlzeCure Pharma AB

Sectra Wins French PACS Replacement Deal Based on its Track Record of Customer Satisfaction

LINKÖPING, Sweden, March 20, 2019 /PRNewswire/ -- International medical imaging IT and cybersecurity company Sectra... Read more ››

By: PR Newswire Association LLC. - 20 Mar 2019
Related companies:  Sectra AB

Cyxone Announces Strategic Intent to Position its Drug Candidate T20K in MS as a Prophylactic Agent

STOCKHOLM, March 20, 2019 /PRNewswire/ -- Cyxone (publ), a Swedish biotech in autoimmune diseases, today announced that preclinical findings support the positioning of its drug candidate T20K as a prophylactic agent for the treatment of multiple sclerosis (MS). This indicates that the substance... Read more ››

By: PR Newswire Association LLC. - 20 Mar 2019
Related companies:  Cyxone AB

Weekend Unlimited CEO Paul Chu Speaks at NYC's CannaGather

NEW YORK, March 20, 2019 /CNW/ -- Weekend Unlimited Inc. ("Weekend" or the "Company") (CSE: POT) (FSE: 0OS1) (OTCQB: WKULF) today announced that CEO Mr. Paul Chu spoke at New York City's CannaGather event on Tuesday, March 20.

Read more ››
By: PR Newswire Association LLC. - 20 Mar 2019

Primex Pharmaceuticals and Nordic Group Sign a Strategic Partnership to Commercialise OZALIN® in France

PARIS and ZUG, Switzerland, March 20, 2019 /PRNewswire/ -- Nordic Group, a pharmaceutical company focusing on the development and commercialisation of hospital and orphan products, and Primex Pharmaceuticals AG, an innovative global Anaesthesia pharmaceutical company, announced a strategic... Read more ››

By: PR Newswire Association LLC. - 20 Mar 2019

Pharmaceutical Collaborations and Rare Diseases Drive the Drugs to Watch as New Blockbusters Are Forecast to Hit the Market in 2019

New report from Clarivate Analytics identifies seven new drugs predicted to achieve annual sales of >$1 billion by 2023

Read more ››
By: PR Newswire Association LLC. - 20 Mar 2019
Related companies:  BioWorld | Clarivate Analytics

Notice of Annual General Meeting in Getinge AB (publ)

GOTHENBURG, Sweden, March 20, 2019 /PRNewswire/ -- The shareholders of Getinge AB (publ), corporate ID No. 556408-5032, are hereby invited to attend the Annual General Meeting (the "AGM") to be held on Tuesday 23 April 2019 at 2.00 p.m. CET, in Kongresshallen, Hotel Tylösand, Halmstad, Sweden.

... Read more ››
By: PR Newswire Association LLC. - 20 Mar 2019

Psychiatry UK and Digital Health Startup, Taliaz, Launch New Online Service to Deliver Groundbreaking Artificial Intelligence-Genetic Testing to Depression Sufferers

Online medically-managed Predictix genetic testing service aims to reduce patient suffering by helping psychiatrists personalize antidepressant medication sooner

Read more ››
By: PR Newswire Association LLC. - 20 Mar 2019

NeoPhore Appoints Dr John Haurum as Non-Executive Director

Former F-star CEO joins the Board of Directors

Read more ››
By: PR Newswire Association LLC. - 20 Mar 2019

MilliporeSigma Opens First M Lab(TM) Collaboration Center in Europe

- Molsheim, France center supports pharmaceutical and biotechnology customers from pre-clinical through full-scale production in non-GMP environment

Read more ››
By: PR Newswire Association LLC. - 20 Mar 2019

Sciton®, Inc. Unveils The HALO(TM) Distinguished Partner Program

PALO ALTO, Calif., March 20, 2019 /PRNewswire/ -- Sciton(®), Inc. a leading manufacturer of high-quality laser and light systems in the medical and aesthetic market, announces the HALO(TM) Distinguished Partner Program. Established to identify excellence in the aesthetic and... Read more ››

By: PR Newswire Association LLC. - 20 Mar 2019
Related companies:  Sciton, Inc.

Apexigen Announces Clinical Data Presentations On CD40 Antibody APX005M At The AACR Annual Meeting 2019

SAN CARLOS, Calif., March 20, 2019 /PRNewswire/ -- Apexigen, Inc., a clinical-stage biopharmaceutical company, today announced new clinical data on APX005M will be presented at the American Association for Cancer Research (AACR) Annual Meeting, to be held March 29 - April 3, 2019 in Atlanta,... Read more ››

By: PR Newswire Association LLC. - 20 Mar 2019
Related companies:  Apexigen, Inc

Arrhythmia Monitoring Devices Market Worth $8.41 Billion by 2025: Grand View Research, Inc.

SAN FRANCISCO, March 20, 2019 /PRNewswire/ --The global Read more ››

By: PR Newswire Association LLC. - 20 Mar 2019
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16 17  18  19  20  21  22  23  24  25 »

Explore our database of over 50,000 companies